Core Management Team

Corporate Social Responsibility

Corporate Social Responsibility (CSR) is the continuing commitment by business to behave ethically and contribute to economic development while improvingthe quality of life of the workforce and their families as well as the local community and society at large.

At IIL, we conduct transparent business operations based on market mechanism within the legal, ethical & social framework with aims to attain the mission reflected by our vision. Our CSR activities also consider the interests of our external & internal stakeholders like customers, employees, vendors, shareholders, society, government etc. and ecological & ethical considerations in all aspects of operations.

During the year, the company supported several NGO requests including Citi FM's Easter Orphanage Programme. The company also receieved a request from Korle-Bu Teaching Hospital leading to the refurbishment of the Pharmacy Department Counselling Center of the Hospital.

MANAGING DIRECTOR

MR. DAVID K. KLUTSE

Mr. David Klutse is the Managing Director of Intravenous Infusions Limited. As the Managing Director, he is responsible for the strategic and day-to-day management of the Company as well as organization of the business of Intravenous Infusions Limited (IIL). He, however, operates under the overall policy direction of the Board of Directors. He coordinates the activities of the Heads of the various departments in order to ensure smooth operation and execution of the production, engineering, marketing, and financial management functions of the company. In addition, he assumes overall responsibility for Human Resource management.

He holds a Master's Degree in Business Administration (MBA) from University of Ghana, Legon. He is a Fellow of the Association of Chartered Certified Accountants (FCCA) - UK. He has over Twenty (20) years in Senior and Executive management positions and prior to this appointment he was the Head of Finance for Golden Beach Hotels (GH) Limited. He has led teams for over eight (8) years in the Pharmaceutical and healthcare service in the UK and has specialty in Pharmaceutical Merges and Acquisitions and Due Diligence, FMCG, Pharmaceutical Start Ups and Pharmaceutical Pricing Regulatory Schemes (PPRS).